Edition:
India

Aerie Pharmaceuticals Inc (AERI.OQ)

AERI.OQ on NASDAQ Stock Exchange Global Market

39.87USD
24 May 2019
Change (% chg)

$0.43 (+1.09%)
Prev Close
$39.44
Open
$39.78
Day's High
$40.22
Day's Low
$39.13
Volume
87,328
Avg. Vol
181,237
52-wk High
$74.75
52-wk Low
$32.19

About

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02%... (more)

Overall

Beta: 1.06
Market Cap(Mil.): $1,913.33
Shares Outstanding(Mil.): 36.34
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates